Key Points An analyst initiated coverage of the rare-earth specialist. He flagged it as a buy. 10 stocks we like better than NioCorp Developments › Specialty mining stock NioCorp Developments (NASDAQ: NB) was able to surmount the hump of Hump Day, closing more than 2% higher in price to contrast favorably with the S&P 500 index's 0.3% decline. A bullish analyst note was an immediate catalyst for the rise. Buy, says bull Freedom Capital Markets' Vitaly Kononov initiated coverage of NioCorp stock that day. He recommends it as a buy, with a price target of $8.70. That's a sturdy 31% higher than the company's most recent closing price. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Kononov's take on NioCorp is based on several factors, according to reports. A critical one is that the company benefits from top-down U.S. government support, as the Trump administration has prioritized the development of rare-earth mining in the country. The pundit also wrote in his inaugural NioCorp note that the company will also benefit from demand from U.S. industrial companies that require rare-earth elements. Finally, Kononov waxed bullish about the quality of the company's deposits and its production, and said it had signed advantageous offtake contracts (in which a customer commits to buying output from a producer in advance). A rare bird There aren't many rare-earth companies in the world, and only a handful are based in the U.S. This gives NioCorp vast, inherent potential, and on that basis alone, I'd be as optimistic as Kononov. The company certainly feels as if it's operating the right business at the right time in this nation's history. Should you buy stock in NioCorp Developments right now? Before you buy stock in NioCorp Developments, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and NioCorp Deve...

匈牙利政府发行30亿欧元债券（折合35亿美元），认购金额大约100亿欧元。

全國男子籃球聯賽，香港金牛大勝江西鯨裕清酒33分。 藍衫的香港金牛，這日移師至福田作為主場出擊，12位上陣球員都有分落袋。外援阿諾斯克攻入今季新高26分，有15分在第二節取得，協助主隊領先江西9分完半場。 金牛第三節爆發，單節打出24-7的比分，將優勢擴大至26分。厄特爾二世今場交出19分。港將吳委峻最後一節上陣，取得2分、1次助攻，以及1次搶斷。金牛大勝101-68，開季連贏六場。

At the recent South Korea-China summit, both sides agreed to improve dialogue, rebuild trust and promote regional peace and stability, marking a first step towards a normalisation of relations. While the Beijing meeting produced no concrete agreement for peace on the Korean peninsula, it reaffirmed the peninsula’s stability and peace as a common interest – paving the way for cooperation. The prolonged stalemate over North Korea’s nuclear programme is no longer just a diplomatic impasse. The Korean peninsula stands at a critical juncture that will determine the future of northeast Asia’s security order. Renewed debate in Japan over nuclear options, alongside strengthened US-Japan extended deterrence , has made it increasingly difficult to treat the issue as one confined to Pyongyang. Regional actors are recalculating their strategic assumptions – with implications that extend well beyond the peninsula. Advertisement As sanctions and pressure fail to produce progress on North Korea’s denuclearisation, crisis management has emerged as a more immediate and realistic challenge. North Korea has publicised advances in its nuclear-powered submarine programme, staged provocative military activities near the demilitarised zone and, around the time of the summit, launched ballistic missiles , reinforcing a sense of strategic uncertainty. Seoul’s recent declaration on pursuing a “nuclear-free Korean peninsula” signals a critical turning point. Shifts are also visible in the foreign and security priorities of Washington and Beijing. Advertisement

歐洲議會37名議員去信歐盟領袖，敦促歐盟譴責美國突襲委內瑞拉。 美軍上周六突襲多個地區，包括委內瑞拉首都加拉加斯，軍方周三為數十名陣亡士兵舉行喪禮，國民警衛隊人員在墓園一帶巡邏。 當地檢察部門批評美國干犯戰爭罪，軍方強調會設法營救總統馬杜羅，撞毀境外恐怖組織。 歐洲議會意大利籍議員德拉瓦萊同日發聲明，稱37名歐洲議會議員去信歐盟委員會主席馮德萊恩和外交與安全政策高級代表卡拉斯，指美軍嚴重違反國際法和《聯合國憲章》原則，可能加劇拉丁美洲緊張局勢。德拉瓦萊又稱，歐盟作為倡導多邊主義和國際法治的重要力量，應該譴責美國。

SANTA CLARA, Calif., January 07, 2026--(BUSINESS WIRE)--Intel Corporation today announced that it will report fourth-quarter and full-year 2025 financial results on Thursday, January 22, 2026, promptly after close of market. Intel will then hold an earnings conference call at 2 p.m. PT that day to discuss the results. A live public webcast of the earnings conference call can be accessed on Intel's Investor Relations website at intc.com. Associated materials and webcast replay will also be available on the site. About Intel Intel (Nasdaq: INTC) designs and manufactures advanced semiconductors that connect and power the modern world. Every day, our engineers create new technologies that enhance and shape the future of computing to enable new possibilities for every customer we serve. Learn more at intel.com. © Intel Corporation. Intel, the Intel logo and other Intel marks are trademarks of Intel Corporation or its subsidiaries. Other names and brands may be claimed as the property of others. View source version on businesswire.com: https://www.businesswire.com/news/home/20260107210694/en/ Contacts Investor Relations investor.relations@intel.com Sophie Metzger Media Relations sophie.metzger@intel.com

Intel sets Jan. 22 date to reveal its 2025 year-end numbers Stock Titan

SANTA CLARA, Calif., January 07, 2026--(BUSINESS WIRE)--Intel Corporation today announced that it will report fourth-quarter and full-year 2025 financial results on Thursday, January 22, 2026, promptly after close of market. Intel will then hold an earnings conference call at 2 p.m. PT that day to discuss the results. A live public webcast of the earnings conference call can be accessed on Intel's Investor Relations website at intc.com. Associated materials and webcast replay will also be available on the site. About Intel Intel (Nasdaq: INTC) designs and manufactures advanced semiconductors that connect and power the modern world. Every day, our engineers create new technologies that enhance and shape the future of computing to enable new possibilities for every customer we serve. Learn more at intel.com. © Intel Corporation. Intel, the Intel logo and other Intel marks are trademarks of Intel Corporation or its subsidiaries. Other names and brands may be claimed as the property of others. View source version on businesswire.com: https://www.businesswire.com/news/home/20260107210694/en/ Contacts Investor Relations investor.relations@intel.com Sophie Metzger Media Relations sophie.metzger@intel.com

Intel to Report Fourth-Quarter and Full-Year 2025 Financial Results Business Wire

New York, Jan 7, 2026, 16:15 (EST) — After-hours Micron shares down about 1.2%, with the day’s range spanning roughly $335 to $346 Company set a Jan. 16 groundbreaking for a planned $100 billion New York “megafab” UBS and Piper Sandler both moved price targets to $400 on tighter memory supply Micron Technology Inc shares were down about 1.2% at $339.45 on Wednesday after trading between $335.10 and $346.24, even as Wall Street pushed price targets higher and the company set a date to break ground on a planned New York factory. The pullback comes as investors crowd into memory and storage names tied to artificial-intelligence spending, where servers need more DRAM — the working memory in computers — and high-bandwidth memory (HBM), a stacked chip used to feed AI processors. Sandisk shares surged 27.6% on Tuesday after Nvidia Chief Executive Jensen Huang highlighted the bottleneck at the Consumer Electronics Show (CES), and Micron and other storage peers also climbed, MarketWatch reported. MarketWatch UBS analyst Timothy Arcuri wrote that investors “underappreciate the degree to which AI has fundamentally made memory (DRAM in particular) a more strategic asset,” after meetings with Micron’s top team. UBS raised its price target to $400 from $300 and lifted its earnings per share (EPS) forecasts for 2026 and 2027, pointing to what it called severe supply shortages that leave Micron meeting only about 50% to 75% of key customer demand. Investing Micron said the Jan. 16 event in Onondaga County, New York, will mark the start of construction on what it called a $100 billion project — a “megafab,” or sprawling semiconductor plant — with up to four fabrication plants. Chief executive Sanjay Mehrotra called the groundbreaking “a pivotal moment for Micron and the United States,” in the company statement. Micron Technology Piper Sandler also raised its price target to $400 from $275 and kept an Overweight rating, saying supply for calendar 2026 is “effectively sold out, with l...

1月8日热门中概股多数下跌， 纳斯达克 中国金龙指数（HXC）收跌1.58%。 上涨股当中（按市值从高到低）， 百度 涨0.27%，携程涨0.08%， 日月光半导体 涨0.69%， 中华电信 涨0.78%， 联电 涨10.04%，中国新城农村涨0.75%， 新东方 涨0.19%。 下跌股当中（按市值从高到低）， 台积电 跌2.64%， 阿里 巴巴 跌2.72%， 拼多多 跌1.36%， 网易 跌3.11%， 京东 跌1.93%， 腾讯音乐 跌5.51%， 富途 控股跌1.81%， 贝壳 跌3.16%，小鹏汽车跌1.11%， 理想 汽车跌0.35%， 中通 跌2.31%， 华住酒店集团 跌2.16%，满帮跌7.67%， 哔哩哔哩 跌1.50%，BOSS直聘跌0.23%， 唯品会 跌0.50%。 美股周三收盘涨跌不一。随着今年初表现火热的某些市场领域失去动力，标普500指数和 道琼斯 工业平均指数创盘中纪录高位之后回落。 道指跌466.00点，跌幅为0.94%，报48996.08点；纳指涨37.10点，涨幅为0.16%，报23584.27点；标普500指数跌23.89点，跌幅为0.34%，报6920.93点。 周三盘中，道指一度上涨至49621.43点，标普500指数最高上涨至6965.69点，二者均创盘中历史新高。 领涨中概股列表： 领跌中概股列表： （截图来自新浪财经APP 行情-美股-中概股热门板块）下载新浪财经APP 责任编辑：张俊 SF065

With cities and towns from Adelaide to Melbourne sweltering through Australia’s worst heatwave in years, it seems the only thing that’s cooling across the nation is inflation. Monthly figures came in lower than expected, boosting the case for a rate hold. In big news overnight, BlueScope Steel rejected the latest takeover bid from US steelmaker Steel Dynamics, while the Trump administration has moved to seize two more sanctioned oil tankers as part of its plans to control Venezuela’s energy resources. - Ben Westcott, Asia Agriculture Reporter What’s happening now BlueScope Steel has rejected the latest takeover approach from US steelmaker Steel Dynamics, arguing the $8.8 billion joint offer made with Australian conglomerate SGH “very significantly” undervalued its assets. Chair Jane McAloon said in a statement that the proposal attempted to take BlueScope from its shareholders “on the cheap.” Good news for homeowners — Australia’s core inflation slowed in November, supporting the case for the Reserve Bank to keep interest rates unchanged for now as it assesses the impact of earlier policy easing. The closely-watched trimmed mean gauge advanced 3.2% from a year ago, easing from 3.3%, while headline CPI rose 3.4%, slower than a forecast 3.6% increase. The New Zealand High Court has issued an urgent injunction barring the publication of stolen medical data after hackers accessed about 430,000 private patient documents held on a health portal used by more than a third of the country’s population. Rare earth-related shares gained in Australia and across the Asia-Pacific region after China imposed a ban on exports of military-use items to Japan, a move with the potential to squeeze supply chains. Lynas Rare Earths was up as much as 16%, the most since July, while metal producer Australian Strategic Materials climbed almost 10%. What happened overnight Here’s what my colleague, market strategist Mike “Willo” Wilson says happened while we were sleeping… A Bloomberg gauge of...

AUDUBON, Pa., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ended December 31, 2025. The company anticipates fourth quarter 2025 sales of approximately $823.2 million, an increase of 25.2 percent over the fourth quarter 2024 on an as-reported basis. Full year 2025 sales are expected to be approximately $2.936 billion, an increase of 16.5 percent over the prior year on an as-reported basis. “We’re thrilled with our preliminary Q4 results, capping off a strong finish to 2025,” commented Keith Pfeil, President and Chief Executive Officer. “Globus closed 2025 with strong momentum, delivering meaningful revenue growth across the business, while advancing operational priorities and integrating the Nevro acquisition. Fourth quarter results reflected the continued trend of growth and market share gains within US Spine, while Enabling Technologies delivered its best quarterly revenue performance to date. We look to 2026 with confidence, remaining focused on driving innovation and operational excellence, introducing a robust pipeline of new products, maintaining disciplined investment, and executing our strategy of sustained, profitable growth.” “Our fourth quarter results demonstrated above market growth as well as continued success in the integration of the NuVasive and Nevro acquisitions,” commented Kyle Kline, Chief Financial Officer. “Excluding the impact of Nevro sales in the fourth quarter, total Globus base business revenue was $723.3 million, an increase of 10.0 percent over the prior year fourth quarter, led by our US Spine business. Looking ahead to 2026, we aim to build upon the successes of the past year, as we drive above market growth and generate value for our shareholders.” The Company established its full year 2026 revenue guidance range of $3.18 billion to $3.22 billion and fully diluted non-GAAP earnin...

白宫和美国能源部高官对如何管控委内瑞拉石油资源作出迄今最明确的表态，称美方已正式启动委内瑞拉石油的全球销售计划，并将“无限期”控制该国未来的石油出口及其收益。这标志着，在强行控制委内瑞拉总统马杜罗后，特朗普政府要开始实质性掌控这个储油大国的最重要资产。 美东时间1月7日周三，白宫新闻秘书莱维特在简报会上表示，美国已开始在全球范围内兜售委内瑞拉石油，销售所得将存入美国控制的银行账户，由美国政府自行决定分配。能源部长赖特在当天一场会议上强调，美方将无限期控制委内瑞拉出口石油的销售，“我们只是要控制资金流动”。 在莱维特讲话前一天，据新华社，美国总统特朗普周二在社交媒体称，委内瑞拉将向美国移交3000万至5000万桶“受制裁的高品质石油”。特朗普写道，这批石油将按市场价出售，所得资金将由他“亲自监管”，并称已要求能源部长赖特立即执行该计划。石油将由油轮接收，并直接运往美国卸货码头。此后报道指出，按市价计算，这批石油价值约28亿美元。 传出特朗普上述表态后，周三亚市早盘，美国WTI原油跌破55.80美元刷新日低，日内跌约2.4%，欧股盘中曾短线转涨，后跌幅扩大，白宫莱维特提到美国开始兜售委内瑞拉石油后，美股午盘曾靠近日低。布伦特原油在美股午盘逼近59.80美元刷新日低，日内跌近1.5%。 最近的报道显示，特朗普政府正推动美国石油企业重建委内瑞拉的石油基础设施。周三媒体称，特朗普政府已与多家石油公司展开磋商，白宫定于周五与能源企业高管举行会晤，美国国务卿鲁比奥可能出席。这一计划建立在美军本周加强对委内瑞拉相关油轮的扣押行动之上。据新华社，美国欧洲司令部周三在社交媒体宣称，连扣两艘油轮，其中一艘悬挂俄罗斯国旗。 此举对全球能源市场和地缘政治格局构成重大影响。美国实际控制委内瑞拉石油出口，不仅改变了该国石油的流向，也可能重塑拉美地区的能源版图，但同时引发了关于国际法和主权的争议。 白宫确认已启动委内瑞拉石油全球销售 白宫新闻秘书莱维特在周三的新闻发布会上表示，美国已开始在全球市场销售委内瑞拉石油。她指出，美国估计有3000万至5000万桶石油因美国制裁而囤积在陆地储罐或油轮中，委内瑞拉临时政府已同意释出这些石油。 莱维特表示，所有委内瑞拉原油及石油产品的销售收益将首先存入美国控制的、在全球公认银行开设的账户，“以此保证最终收益分配的合法性和完整性”。这些资金将由美国政府自行决定，...

Stablecoin Titan Tether Wants Gold To Be Used For Everyday Payments—Here's How Authored by André Beganski via decrypt.co , In brief Tether introduced the term Scudo on Tuesday to represent 1/1,000th of a troy ounce of gold. The stablecoin issuer thinks the term could bolster gold’s use in payments. Tether issues a gold-backed token, XAUT, and holds nearly $17 billion worth of gold. Tether moved to establish a new unit of account for gold on Tuesday , as the stablecoin industry leader argued that transactions denominated in “ Scudo ” could simplify the precious metal’s use in everyday payments. Under the stablecoin issuer’s definition, one Scudo would equate to one-thousandth of a troy ounce of gold —as well as its XAUT token, which is valued at $2.3 billion, according to CoinGecko . The token’s market cap has nearly quadrupled over the past year. In a blog post , Tether acknowledged that demand for gold has been bolstered worldwide by “persistent inflation concerns, heightened interest-rate uncertainty, record central bank purchases, and growing demand for safe-haven assets.” Although a lion’s share of the firm’s products are pegged to the U.S. dollar, it described those factors as an “opportunity to restore gold” to its former status: a universally accepted medium of exchange that can’t be devalued by a government’s ability to print money. The company added that its wallet developer kit can help support XAUT on virtually any device. Tether noted that “satoshi” is already used in a similar way to Scudo, as a way to refer to the smallest unit of Bitcoin, or one hundred-millionth of a Bitcoin . One satoshi is currently worth around $0.001, while one Scudo would be worth roughly $4.48. Tether’s term dates back to the 16th century, more than 400 years before the first version of the internet was developed. Scudo was used to describe a variety of coins in Italy, likely hammered from metal blanks. The term was derived from the Latin word for shield. Introducing Scudo. A n...

彭博美元指数小幅走高，全天走势震荡，此前公布的美国服务业活动和私营部门就业数据所反映的经济状况喜忧参半。 彭博美元指数上涨0.1%，此前在伦敦和纽约交易时段涨涨跌跌，震荡反复。 供应管理学会（ISM）服务业指数报54.4，预估为52.2；ADP私营部门就业人数增加4.1万人，预估为增加5万人。 “ISM服务业指数仍显示服务业活动稳健，但价格压力缓解应会促使美联储继续保持鸽派立场，”Brown Brothers Harriman全球市场策略主管Elias Haddad表示。 美国12月就业报告将于周五公布；市场预估非农就业人数增加7万人。 10年期美国国债收益率下跌约3.5个基点，至4.14%；美国股市涨跌互现。 美元/日元上涨不到0.1%，报156.74。 欧元/美元持稳，报1.1682；英镑/美元下跌0.3%，报1.3465。 澳元/美元下跌0.2%，报0.6728；此前数据显示，澳大利亚11月核心通胀放缓。 根据彭博汇编的数据，市场几乎已完全计入5月首次加息的预期，高于周一时约80%的概率。 “整体数据走软意味着，投资者对紧缩周期启动时间的预期将后移，”东方汇理银行高级策略师David Forrester表示。 部分信息来自熟悉交易情况但因未获授权公开发言而要求匿名的外汇交易员。 责任编辑：李桐

Wednesday, January 7, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Micron Technology, Inc. (MU), Roche Holding AG (RHHBY) and UnitedHealth Group Inc. (UNH). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. You can see all of today’s research reports here >>> Ahead of Wall Street The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning. You can read today's AWS here >>> ADP Rebounds to +41K, JOLTS & ISM Services After the Open Today's Featured Research Reports Micron Technology’s shares have outperformed the Zacks Computer - Integrated Systems industry over the past six months (+186.2% vs. +61.2%). The company is benefiting from the rapidly expanding artificial intelligence (AI)-driven memory and storage markets. The positive impacts of inventory improvement across multiple end markets are driving top-line growth. The surging demand for HBM and robust DRAM pricing recovery will aid significant revenue and earnings growth in the coming quarters. Its solid financials, positive free cash flow and strong balance sheet provide the flexibility to invest in growth initiatives while enhancing shareholder value. Micron Technology’s long-term customer agreements and expanding AI partnerships reduce volatility and enhance revenue visibility. Nonetheless, rising operating costs and a massive increase in capital expenditure pose a downside risk to Micron’s near-term profitability. (You can read the full research report on...

格隆汇1月8日｜美国总统特朗普发文称，他从国防部处获悉，国防承包商雷神科技(RTX.N)对国防部的需求响应最不积极，产能提升速度最慢，且其资金投入大多流向了股东，而非美国军队的需求和要求。特朗普威胁称，雷神公司要么加大投入，比如在厂房和设备方面进行更多投资，要么不再与国防部开展业务。特朗普补充称，如果雷神公司希望继续与美国政府合作，在整顿到位前，无论如何公司都不得再进行任何股票回购——此前他们已为此耗费数百亿美元。

NEW YORK, Jan 7, 2026, 15:47 EST — Regular session Tesla, Inc. shares were little changed on Wednesday, up 0.4% at $434.75 in afternoon trading, as investors weighed fresh signs of weakness in Europe against a renewed burst of interest in autonomous-driving tech. The stock has traded between $431.66 and $438.35 so far in the session. Germany’s road traffic agency KBA said Tesla sold 2,032 cars in December, down 48% from a year earlier, while its 2025 registrations in the country fell 48.4% to 19,390 units. The data underscored how quickly the U.S. automaker is losing ground in Europe even as overall electric-vehicle registrations in Germany rose 43.2% in 2025, and BYD’s December sales jumped more than 12-fold to 4,109 vehicles. Reuters The timing matters because Tesla heads into its next earnings report with investors looking for a clearer read on demand, pricing and margins after a softer year for deliveries. Tesla said it delivered 418,227 vehicles in the fourth quarter and 1,636,129 in 2025, and it scheduled its fourth-quarter results and webcast for Jan. 28 after market close. Tesla Investor Relations The stock’s recent swings have also tracked the market’s obsession with self-driving and robotics — a big part of the premium some investors put on Tesla beyond its car business. Nvidia on Jan. 5 rolled out “Alpamayo,” a set of open-source autonomous-driving models and tools, with CEO Jensen Huang calling it “the ChatGPT moment for physical AI,” while Tesla shares fell 4.14% on Tuesday. NVIDIA Newsroom Tesla CEO Elon Musk tried to play down the competitive threat, writing on social media: “I’m not losing any sleep about this,” MarketWatch reported. He said any real pressure would take years to show up as carmakers redesign vehicles around cameras and computing hardware. MarketWatch Competition is also building around humanoid robots, another area Musk has pitched as a long-term growth driver. Mobileye said it would buy humanoid robotics startup Mentee Robotics for ...

Elon Musk is "unstoppable." And Globalstar's rally just got stopped. Easy come, easy go. Shares of Globalstar (GSAT 9.58%) stock, the satellite communications company that's helping Apple (AAPL 0.77%) offer emergency SOS text service to its customers in cellphone dead zones, surged 5% on Tuesday after Clear Street brokerage raised its price target to $71. On Wednesday, however, the stock gave back all those gains and more, closing the day down 9.6%. Why? Globalstar, global worries In its note yesterday, Clear Street argued Globalstar stock looks "compelling" because its Apple contract makes it "de-risked," while the company has upside from selling its services to the government, as TheFly.com relates. A note from Scotiabank today, however, highlights other risks to Globalstar that Clear Street may have overlooked. Specifically, in the course of downgrading shares of AST SpaceMobile (ASTS 12.08%), Scotiabank pointed out the wide disparity in capabilities between AST and SpaceX's Starlink satellite communications network, which is launching new satellites -- many equipped for direct-to-cell service -- at the rate of more than 3,000 per year. That's a lot more than AST's mere six satellites in orbit -- but also quite a bit more than the two dozen satellites that Globalstar possesses. Advertisement Expand NASDAQ : GSAT Globalstar Today's Change ( -9.58 %) $ -6.45 Current Price $ 60.85 Key Data Points Market Cap $8.5B Day's Range $ 60.58 - $ 67.36 52wk Range $ 17.24 - $ 74.88 Volume 866K Avg Vol 1.1M Gross Margin 31.29 % Is Globalstar stock a sell? Furthering the contrast, says Coello, is the "global brand recognition" of SpaceX's Starlink system of communications satellites, that AST (and Globalstar) lack. This helps SpaceX to capitalize upon its rapid deployment of satellites. Coello calls SpaceX and Starlink "unstoppable." These companies could become even more unstoppable after SpaceX conducts a $1.5 trillion IPO later this year, flooding the company with cash that i...

Key Points Globalstar got a nice hike to target price yesterday. Today the stock is tumbling -- apparently on a bad report regarding its rival AST SpaceMobile. 10 stocks we like better than Globalstar › Easy come, easy go. Shares of Globalstar (NASDAQ: GSAT) stock, the satellite communications company that's helping Apple (NASDAQ: AAPL) offer emergency SOS text service to its customers in cellphone dead zones, surged 5% on Tuesday after Clear Street brokerage raised its price target to $71. On Wednesday, however, the stock gave back all those gains and more, closing the day down 9.6%. Why? Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Globalstar, global worries In its note yesterday, Clear Street argued Globalstar stock looks "compelling" because its Apple contract makes it "de-risked," while the company has upside from selling its services to the government, as TheFly.com relates. A note from Scotiabank today, however, highlights other risks to Globalstar that Clear Street may have overlooked. Specifically, in the course of downgrading shares of AST SpaceMobile (NASDAQ: ASTS), Scotiabank pointed out the wide disparity in capabilities between AST and SpaceX's Starlink satellite communications network, which is launching new satellites -- many equipped for direct-to-cell service -- at the rate of more than 3,000 per year. That's a lot more than AST's mere six satellites in orbit -- but also quite a bit more than the two dozen satellites that Globalstar possesses. Is Globalstar stock a sell? Furthering the contrast, says Coello, is the "global brand recognition" of SpaceX's Starlink system of communications satellites, that AST (and Globalstar) lack. This helps SpaceX to capitalize upon its rapid deployment of satellites. Coello calls SpaceX and Starlink "unstoppable." These companies could become even more unstoppable after SpaceX conducts a $1....

Amazon stock price forecast: high probability of further gains as AMZN trades above key supports Traders Union

0P0000ZJ5Z 互動股市圖表 | Multi Stars Sicav Sureco US Cor 股市 Yahoo 財經

The high-profile private lawyer for Nick Reiner was granted a request to be removed from his case Wednesday, but later told reporters that according to California law his client is not guilty of murder in the killing of his parents, Rob Reiner and Michele Singer Reiner. “Circumstances beyond our control and more importantly circumstances beyond Nick’s control have dictated that, sadly, it’s made it impossible to continue our representation of Nick,” lawyer Alan Jackson said as he stood with his team outside a Los Angeles courthouse. But, Jackson added, after weeks of investigation, “what we’ve learned, and you can take this to the bank, is that pursuant to the laws of this state, pursuant to the law of California, Nick Reiner is not guilty of murder. Print that.” Advertisement Jackson would not specify what he meant and took no questions at the brief news conference. He spoke after a hearing where Nick Reiner was supposed to be arraigned and enter a plea to two charges of first-degree murder. Instead, after meeting with the Judge Theresa McGonigle in chambers, Jackson was replaced by a public defender and Reiner’s plea hearing was postponed to February 23. Nick Reiner attends the Los Angeles premiere of “Spinal Tap II: The End Continues” in September 2025. Photo: Reuters Jackson said that for legal and ethical reasons, he could not reveal why he had to leave the case.

立法會主席｜陳振英：完全信服結果 無礙與李慧琼合作 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】落選的陳振英指完全信服結果，不會因此影響與李慧琼的合作，被問及今屆會否角逐內會主席，他指持開放態度。 陳振英：「對於今日的結果，我自己是完全信服的，因為這是我們所有議員的選擇，過了這個投票後，我與李慧琼仍然會像以前一樣合作無間。輸多少票其實不重要，輸一票也是輸，像做運動員踢波，輸一球一比零就是輸了比賽，都是全失三分，所以這並不會有甚麼不甘心。反而將來，我認為內會、財會或其他崗位，正如我在當選日已說清楚，我自己持開放態度，如果大家覺得我合適擔任甚麼崗位，我都樂意承擔相關職務。」

In this video, I will discuss Nebius (NASDAQ: NBIS) and share my thoughts on it as we begin 2026. Watch the short video to learn more, consider subscribing, and click the special offer link below. *Stock prices used were from the trading day of Jan. 3, 2026. The video was published on Jan. 3, 2026. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Should you buy stock in Nebius Group right now? Before you buy stock in Nebius Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nebius Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $488,653!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,148,034!* Now, it’s worth noting Stock Advisor’s total average return is 971% — a market-crushing outperformance compared to 196% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors. See the 10 stocks » *Stock Advisor returns as of January 7, 2026. Neil Rozenbaum has positions in Nebius Group. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Neil is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Key Points Eli Lilly's GLP-1 weight loss drug is leading investors to award it a massive P/E ratio of 53. That's far higher than the pharmaceutical sector's average P/E ratio of about 30. Merck, Bristol Myers Squibb, and Pfizer have P/E ratios of 14, 18, and 15, respectively. 10 stocks we like better than Bristol Myers Squibb › Over short periods, Wall Street is largely driven by emotions. When there's a compelling story, such as the emergence of GLP-1 weight loss drugs in the pharmaceutical sector, investors tend to become overly excited. Eli Lilly's (NYSE: LLY) industry-leading GLP-1 drugs have netted it a price-to-earnings ratio (P/E) of 53. Other well-respected drugmakers, meanwhile, have been left to languish. This is why contrarian investors should take a look at Merck (NYSE: MRK), Bristol Myers Squibb (NYSE: BMY), and Pfizer (NYSE: PFE) today. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Far below average valuation Eli Lilly's 53 P/E ratio is huge. The stock price advance that led to that valuation has pushed the dividend yield down to a shockingly low 0.6%. The average P/E for the drug sector is roughly 30, with an average yield of around 1.3%. From a valuation perspective, it's pretty clear that investors are affording Eli Lilly a premium price. There are other large and historically successful drugmakers that aren't trading at a premium. For example, Merck's P/E ratio is 14, and its dividend yield is 3.2%. Bristol Myers Squibb's P/E is 18, and its yield is 4.7%. And Pfizer's P/E ratio is 15 while its yield is 6.8%. If you look at these valuations, these three drugmakers appear to be trading at a discount. There are good reasons for the relatively low valuations being afforded to Merck, Bristol Myers Squibb, and Pfizer. However, these are companies that have consistently proven over time that they can discover, develop, and market innovative drugs. The problem is that ...

00:00 > > "BLOOMBERG TECH" IS LIVE FROM COAST-TO-COAST. WITH KATIE GREIFELD IN NEW YORK AND ED LUDLOW IN SAN FRANCISCO. CAROLINE HYDE IN NEW YORK AND ED LUDLOW IN SAN FRANCISCO. ED: WELCOME TO A SPECIAL EDITION OF BLOOM BERK AT THING LIKE FROM C.E.S. IN LAS VEGAS. WE HAVE BEEN BRINGING YOU CONVERSATIONS FROM THE BIGGEST NAMES IN THE INDUSTRY. TODAY WE HAVE ANOTHER GREAT LINEUP. FIRST WE SIT DOWN WITH JIM JOHNSON OF INTEL’S CLIENT COMPUTING GROUT TO DISCUSS THE CHIPMAKER’S EFFORTS TO MAKE PRODUCTS COMPETITIVE AGAIN. CAROLINE: A TAKEOVER FROM PARAMOUNT. ED: MOBILIZE C.E.O. TO DISCUSSION THE ACQUISITION OF ISRAELI A DEAL VALUED AT $900 MILLION. CAROLINE: CHECK IN ON THE MARKETS. HAVE BEEN RULED BY GOO POLITICS. NASDAQ MANAGING TO BRUSH THAT OFF. WE ARE STILL RECORD HIGHS IN THE S & P. UP ANOTHER .3% ON THE MAIN BENCHMARK WHEN IT COMES TO THE TECH NAMES. MAYBE LESS AFFECTED BY WHAT’S HAPPENING IN TERMS OF GEOPOLITICS AND RUSSIA AND THE U.S. AT THE MOMENT OUT IN THE SEAS. WE CURRENTLY HOLDING ON TO GAINS. ED: GEOPOLITICS IS ALWAYS THERE. LOOKING AT NVIDIA, IT IS THE MAINSTAY OF THIS C.E.S. WHICH. THE STOCK IS UP ALMOST 1.5% IN THE CURRENT SESSION. THERE ARE HEADLINES OUT FROM THE INFORMATION THAT CHINA IS ASKING ITS TECH COMPANIES TO HALT ORDERS OF H-200. THEY HAVE BEEN PEPPERED WITH QUESTIONS. YOU CAN SEE OVER THREE DAYS THIS WAS NOT THE BLOCKBUSTER WE THOUGHT IT WOULD BE IN THE START OF THE YEAR. NVIDIA UP HALF A PERCENTAGE POINT. THE BIG DATA POINT WAS THE FORECAST FOR THE NEXT FEW QUARTERS. BLACKWELL AND RUBEN. THIS IS WHAT THEY HAD TO SAY ABOUT THAT FORECAST. > > HARPER PRICING IS GOING UP IN THE CLOUD. ALL OF THE HOPPERS ARE CONSUMED IN CLOUD AND NOW PRICING, SPOT PRICING IS STARTING TO GO UP. THAT TELLS YOU ABOUT THE DEMAND THAT’S BEING GENERATED ALL OVER THE WORLD. H-200’S WILL CONTRIBUTE TO THAT. I THINK ALL TOLD I THINK WE SHOULD HAVE A VERY GOOD YEAR. ED: THAT QUESTION WAS POSED TO JENSEN BY IAN KING WHO COVERED SEMICONDUCTORS HERE SINCE 1998, AND THE CONTEXT ...

UK Athletics’ chief executive, Jack Buckner, has described Reece Prescod’s decision to participate in the controversial Enhanced Games as “appalling”. Former Great Britain sprinter Prescod gave a statement to the Times saying he is “very excited” to be joining the sprinting field of the event. The Enhanced Games allows the use of performance-enhancing substances and permits athletes to take substances approved by the United States Food and Drug Administration (FDA), under strict supervision. In a statement, former Olympic long-distance runner Buckner said: “As a former athlete, I find this particularly appalling. Those of us who have competed know what it takes to succeed the right way – through talent, dedication, and respect for the rules. To see a British athlete aligning themselves with an event that celebrates the use of performance-enhancing drugs is profoundly disappointing.” In September 2025, the Olympic silver swimming medallist Ben Proud announced that he would be participating in the event, making him the first British athlete to join. Prescod won a silver medal at the 2018 European Championships and competed at Tokyo 2020 before announcing his retirement in August last year. The statement from UK Athletics added: “UK Athletics is disappointed by reports that former Great Britain sprinter Reece Prescod intends to take part in the so-called Enhanced Games. “UKA does not recognise the Enhanced Games as a legitimate sporting competition. Any event that promotes or permits the use of harmful substances with the aim of pushing the human body to its limit for short-term goals is not sport as we value it. “This concept fundamentally undermines the integrity of competition, places athletes’ health and welfare at serious risk, and is incompatible with the principles of clean sport that underpin athletics in the UK and worldwide. The very reason clean sport exists is because those involved saw the risks that resulted from athletes taking substances that led to sev...